These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14198442)

  • 1. PRESERVATIVES FOR POLIOMYELITIS (SALK) VACCINE. II. FORMALDEHYDE AND ESTERS OF P-HYDROXYBENZOIC ACID.
    TRACY JM; GLASS DG; NICHOLSON MJ; PIVNICK H
    J Pharm Sci; 1964 Jun; 53():659-63. PubMed ID: 14198442
    [No Abstract]   [Full Text] [Related]  

  • 2. PRESERVATIVES IN POLIOMYELITIS (SALK) VACCINE.
    TRACY J; PIVNICK H; GLASS DG
    Bull Parenter Drug Assoc; 1964; 18():6-24. PubMed ID: 14107092
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDIES OF PRESERVATIVES OF POLIOMYELITIS (SALK) VACCINE. I. BENZETHONIUM CHLORIDE.
    PIVNICK H; TRACY JM; GLASS DG
    J Pharm Sci; 1963 Sep; 52():883-8. PubMed ID: 14061050
    [No Abstract]   [Full Text] [Related]  

  • 4. [STUDIES ON TESTS FOR THE NON-TOXICITY OF INACTIVATED POLIOMYELITIS VACCINES. 1. INFLUENCE OF MAGNESIUM CHLORIDE ON THE SUSCEPTIBILITY OF MONKEY KIDNEY CELL CULTURES TO FORMALIN-TREATED POLIOMYELITIS VIRUS].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Nov; 190():313-21. PubMed ID: 14105973
    [No Abstract]   [Full Text] [Related]  

  • 5. p-Hydroxybenzoic acid esters as preservatives. III. The physiological disposition of p-hydroxybenzoic acid and its esters.
    JONES PS; THIGPEN D; MORRISON JL; RICHARDSON AP
    J Am Pharm Assoc Am Pharm Assoc; 1956 Apr; 45(4):268-73. PubMed ID: 13319107
    [No Abstract]   [Full Text] [Related]  

  • 6. PRESERVATIVES FOR POLIOMYELITIS (SALK) VACCINE. 3. 2-PHENOXYETHANOL.
    PIVNICK H; TRACY JM; TOSONI AL; GLASS DG
    J Pharm Sci; 1964 Aug; 53():899-901. PubMed ID: 14241801
    [No Abstract]   [Full Text] [Related]  

  • 7. RELATIVE STABILITY OF PERTUSSIS VACCINE PRESERVED WITH MERTHIOLATE, BENZETHONIUM CHLORIDE, OR THE PARABENS.
    GARDNER RA; PITTMAN M
    Appl Microbiol; 1965 Jul; 13(4):564-9. PubMed ID: 14339263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 9. THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. II. RELATIONSHIP OF POLIOMYELITIS TO CUTTER VACCINE.
    NATHANSON N; LANGMUIR AD
    Am J Hyg; 1963 Jul; 78():29-60. PubMed ID: 14043545
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():152-75. PubMed ID: 13725917
    [No Abstract]   [Full Text] [Related]  

  • 11. [RESULTS WITH SALK TYPE POLIOMYELITIS VACCINE IN CORDOBA].
    GIMENODESANDE A
    Rev Sanid Hig Publica (Madr); 1965; 39():185-221. PubMed ID: 14307031
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of roosters in the antigenicity testing of Salk poliomyelitis vaccine.
    FURESZ J; MOREAU P
    J Immunol; 1963 Feb; 90():192-200. PubMed ID: 13945854
    [No Abstract]   [Full Text] [Related]  

  • 13. Poliomyelitis antibody levels of young children in Houston, 1961-62. Existence of susceptible pockets in an area using Salk vaccine of high effectiveness.
    ASHKENAZI AE; MELNICK JL
    Tex Rep Biol Med; 1962; 20():550-4. PubMed ID: 13965180
    [No Abstract]   [Full Text] [Related]  

  • 14. RESPONSE TO ONE DOSE OF TRIVALENT ORAL POLIOVACCINE IN CHILDREN PREVIOUSLY IMMUNISED WITH SALK VACCINE: A COMPARISON OF LIQUID VACCINE AND A CAPSULE PRESENTATION.
    BEALE AJ; DAVIES JR; THROWER AL
    Lancet; 1965 Apr; 1(7391):879-81. PubMed ID: 14272682
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of the Louisiana State Board of Health experience with the use of Salk vaccine and comments on the Sabin oral polio vaccine.
    HEDMEG A
    J La State Med Soc; 1963 Feb; 115():41-7. PubMed ID: 13963684
    [No Abstract]   [Full Text] [Related]  

  • 16. [COLOR REACTION WITH XANTHYDROL. IV. MECHANISMS OF COLOR REACTIONS OF PHENOLS. (3). STUDIES ON REACTIONS OF CRESOLS AND HYDROXYBENZOIC ACIDS].
    MIZUKAMI S; KANAYA Y
    Yakugaku Zasshi; 1964 Jan; 84():52-6. PubMed ID: 14113564
    [No Abstract]   [Full Text] [Related]  

  • 17. [ON THE OCCURRENCE OF A POLIOMYELITIS OUTBREAK IN THE COMMUNE OF CARRARA AFTER THE VACCINATION CAMPAIGN OF 1958-1960 WITH SALK VACCINE].
    BARGHINI G; GALLO G
    Riv Ital Ig; 1964; 24():590-6. PubMed ID: 14337305
    [No Abstract]   [Full Text] [Related]  

  • 18. THE SOLUBILISATION AND INACTIVATION OF PRESERVATIVES BY NON-IONIC DETERGENTS.
    EVANS WP
    J Pharm Pharmacol; 1964 May; 16():323-31. PubMed ID: 14195674
    [No Abstract]   [Full Text] [Related]  

  • 19. THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. I. BACKGROUND.
    NATHANSON N; LANGMUIR AD
    Am J Hyg; 1963 Jul; 78():16-28. PubMed ID: 14043543
    [No Abstract]   [Full Text] [Related]  

  • 20. THE PROTECTIVE EFFECT OF SALK VACCINE DURING AN EPIDEMIC OF POLIOMYELITIS, BRITISH COLUMBIA, 1959-1960.
    LARSEN AA
    Can J Public Health; 1965 Feb; 56():47-50. PubMed ID: 14281078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.